References
- Part of the Japan Society for Cancer Therapy. Criteria of the effective therapy in the head and neck cancer. J Jpn Soc Cancer Ther
- Koyama Y, Saitou T. Criteria of the chemotherapy effect in the solid cancer. J Jpn Soc Cancer Ther 1986; 21: 943–53
- Arcamone F, Cassinelli G, Fautin G, et al. Adriamycin 1–4-hydroxydaunomycin, a new antitumor antibiotic from S. peucetius var. caesinus. Biotechnol Bioeng 1969; 11: 1101–9
- Umezawa A, Takahashi T, Ishizuka M, et al. Tetrahy-dropyranyl derivatives of daunomycin and adriamycin. J Antibiot 1979; 32: 1082–4
- Dantchev D, Paitrand M, Hayat M, et al. Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy. J Antibiot 1979; 32: 1085–6
- Takamoto S, Ota K. Flow cytometric analysis of the effect of THP-adriamycin on the cell cycle traverse of RPMI-8402 cells-comparison with adriamycin. Jpn J Cancer Chemother 1986; 13: 1868–75
- Fujii M, Ohno Y, Kanzaki J. Effects of anticancer drugs and combination effects of anthracyclines on the hypoxic cells of head and neck cancer. Jpn J Cancer Chemother 1995; 22: 647–52
- Sugasawa M, Nibu I, Ichimura K, et al. Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma–a group study. Jpn J Cancer Chemother 1994; 21: 969–74